Fake COVID vax proofs sold to healthcare workers

Amy Baxter | | Health Exec | COVID-19
vaccine syringe covid-19 coronavirus

Fake COVID-19 vaccine cards were sold for $200 apiece to individuals in the New York City area, including some healthcare professionals.

The fake cards were sold by a New Jersey woman under the name AntiVaxMomma on Instagram, NPR reported. Jasmine Clifford was charged with offering a false instrument, criminal possession of a forged instrument and conspiracy for allegedly selling roughly 250 fake vaccine cards.

At a higher cost of $250, a second individual, Nadayza Barkley, entered the name of the fake card buyer into a New York state vaccination database that verifies vaccination status at required settings. According to prosecutors, Barkley entered at least 10 names into the vaccine database, NPR reported. Another 13 card buyers were also charged. 

Fake vaccine cards are a rising concern, particularly amid reports of healthcare workers taking part. 

See the full story below:

 

Fake Vaccination Cards Were Sold To Health Care Workers On Instagram

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Monitoring acute heart patients at home linked to considerable cost savings
Brazen marital healthcare scheme ends with guilty pleas
CityMD agrees to $12M settlement over alleged COVID claims fraud
Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes
Does Covid-19 raise risk for cancers—including rare ones?
FDA panel recommends new COVID-19 booster

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.